F · Healthcare

NeutriSci International Inc (1N9)

Drug Manufacturers - Specialty & Generic

NeutriSci International Inc (1N9) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 1N9

P/E ratio

18.00

NeutriSci International Inc (1N9) — FAQ

What is 1N9's P/E ratio?

The price-to-earnings (P/E) ratio for NeutriSci International Inc (1N9) is 18.00 (data as of 2026-03-23).

Does NeutriSci International Inc pay a dividend?

Dividend yield is not available in the current snapshot for NeutriSci International Inc (1N9). Check the MyAverix Finance app for the latest dividend data.

What sector is NeutriSci International Inc in?

NeutriSci International Inc (1N9) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is 1N9 listed on?

1N9 is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)